Literature DB >> 31633582

Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for 5-year hypertension remission in obese patients: a systematic review and meta-analysis.

Elisenda Climent1,2, Albert Goday1,2,3,4, Juan Pedro-Botet1,2,3, Ivan Solà5,6, Anna Oliveras7,8, José Manuel Ramón3,9, Juana Antonia Flores-Le Roux1,2,3, Miguel Ángel Checa10,11,12, David Benaiges1,2,3.   

Abstract

: Controversial results exist on mid-term effects of Roux-en-Y gastric bypass and sleeve gastrectomy on hypertension remission. The aim of the present systematic review was to study 5-year hypertension remission after both procedures. One-year hypertension remission and SBP and DBP pressure change at 1 and 5 years after both surgical techniques were also evaluated. We searched MEDLINE, EMBASE and The Cochrane Central Register of Controlled Trials (CENTRAL). Thirty-two articles were included (six randomized controlled trials, 18 cohort and eight case-control studies). The proportion of patients with hypertension remission was greater for those treated with gastric bypass compared with sleeve gastrectomy at 5 years (RR = 1.26, 95% CI = 1.07-1.48) and 1 year (RR = 1.14, 95% CI = 1.06-1.21). Gastric bypass and sleeve gastrectomy did not differ in terms of SBP or DBP change. Patients treated with gastric bypass present a higher hypertension remission rate at 1 and 5 years.

Entities:  

Mesh:

Year:  2020        PMID: 31633582     DOI: 10.1097/HJH.0000000000002255

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Two-year outcomes of Roux-en-Y gastric bypass vs medical treatment in type 2 diabetes with a body mass index lower than 32.5 kg/m2: a multicenter propensity score-matched analysis.

Authors:  J Ling; H Tang; H Meng; L Wu; L Zhu; S Zhu
Journal:  J Endocrinol Invest       Date:  2022-05-21       Impact factor: 5.467

Review 2.  Changes in Antihypertensive Medication Following Bariatric Surgery.

Authors:  Gabriel S Tajeu; Emily Johnson; Mason Buccilla; Crystal A Gadegbeku; Shane Janick; Daniel Rubin; Rohit Soans; Vikram J Eddy; David B Sarwer
Journal:  Obes Surg       Date:  2022-01-26       Impact factor: 3.479

3.  Remission and Relapse of Dyslipidemia After Vertical Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass in a Racially and Ethnically Diverse Population.

Authors:  Karen J Coleman; Anirban Basu; Lee J Barton; Heidi Fischer; David E Arterburn; Douglas Barthold; Anita Courcoulas; Cecelia L Crawford; Benjamin B Kim; Peter N Fedorka; Edward C Mun; Sameer B Murali; Kristi Reynolds; Robert E Zane; Sami Alskaf
Journal:  JAMA Netw Open       Date:  2022-09-01

4.  Comparative Effectiveness of Gastric Bypass and Vertical Sleeve Gastrectomy for Hypertension Remission and Relapse: The ENGAGE CVD Study.

Authors:  Kristi Reynolds; Lee J Barton; Anirban Basu; Heidi Fischer; David E Arterburn; Douglas Barthold; Anita Courcoulas; Cecelia L Crawford; Benjamin B Kim; Peter N Fedorka; Edward C Mun; Sameer B Murali; Robert E Zane; Karen J Coleman
Journal:  Hypertension       Date:  2021-08-09       Impact factor: 9.897

5.  Remission, relapse, and risk of major cardiovascular events after metabolic surgery in persons with hypertension: A Swedish nationwide registry-based cohort study.

Authors:  Erik Stenberg; Richard Marsk; Magnus Sundbom; Johan Ottosson; Tomas Jernberg; Ingmar Näslund; Erik Näslund
Journal:  PLoS Med       Date:  2021-11-01       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.